Live from the NIH registry
Studies recruiting near Vancouver right now
Top 25 of 1,030 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Oregon Health and Science University Physicians Pavilion (Adults and Pediatrics) — Portland, Oregon (8.7 mi)
· Sponsor: Pierre Fabre Medicament
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Oregon Health & Science University — Portland, Oregon (8.7 mi)
· Sponsor: Syndax Pharmaceuticals
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Northwest Cancer Specialists — Portland, Oregon (8.7 mi)
· Sponsor: Kartos Therapeutics, Inc.
Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder
Alcohol Use Disorder
Phase 4
Interventional 100 participants sought
VA Portland Health Care System — Portland, Oregon (8.7 mi)
· Sponsor: Milky Kohno
Support Via Technology: Living and Learning With Advancing Dementia-REVISED
Caregiver Burden
N/A
Interventional 238 participants sought
Oregon Health & Science University, Layton Aging and Alzheimer's Disease Research Center — Portland, Oregon (8.7 mi)
· Sponsor: Oregon Health and Science University
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Regeneron Pharmaceuticals
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
The Oregon Clinic — Portland, Oregon (8.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Eli Lilly and Company
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
The Oregon Clinic — Portland, Oregon (8.7 mi)
· Sponsor: Eli Lilly and Company
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Northwest Cancer Specialists — Vancouver, Washington (3.1 mi)
· Sponsor: Immuneering Corporation
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
Transthyretin Amyloid Cardiomyopathy
N/A
Observational 500 participants sought
Research Site — Portland, Oregon (8.7 mi)
· Sponsor: AstraZeneca
OCT Angiography in Wet AMD
Neovascular (Wet) Age-related Macular Degeneration (AMD)
N/A
Observational 160 participants sought
Casey Eye Institute, Oregon Health & Science University — Portland, Oregon (8.7 mi)
· Sponsor: Oregon Health and Science University
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
Oregon Health &Science University — Portland, Oregon (8.7 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
Oregon Health and Science University — Portland, Oregon (8.7 mi)
· Sponsor: Parkinson's Foundation
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
Atrial Fibrillation, Esophageal Carcinoma
Phase 2
Interventional 90 participants sought
OHSU Knight Cancer Institute — Portland, Oregon (8.7 mi)
· Sponsor: OHSU Knight Cancer Institute
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Hoffmann-La Roche
JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction
Patellar Dislocation, Recurrent, Patellar Dislocation
N/A
Observational 850 participants sought
Oregon Health & Science University — Portland, Oregon (8.7 mi)
· Sponsor: Hospital for Special Surgery, New York
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Portland, Oregon (8.7 mi)
· Sponsor: Sameek Roychowdhury
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
The Oregon Clinic - Portland - Northwest 22nd Avenue- Site Number : 8400065 — Portland, Oregon (8.7 mi)
· Sponsor: Sanofi
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
Providence St. Vincent Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Joseph Broderick, MD
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Advanced Research Institute - Portland — Tigard, Oregon (16.5 mi)
· Sponsor: Ardelyx
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
Oregon Clinic — Portland, Oregon (8.7 mi)
· Sponsor: Duke University
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Oregon Health and Science University — Portland, Oregon (8.7 mi)
· Sponsor: Novartis Pharmaceuticals
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
Asthma, Pulmonary Function
N/A
Observational 225 participants sought
Oregon Health and Science University (OHSU) — Portland, Oregon (8.7 mi)
· Sponsor: Oregon Health and Science University
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Vancouver, Washington (3.1 mi)
· Sponsor: AstraZeneca